The Pharmacovigilance Program of India (PvPI) was launched in 2010 by Ministry of Health & Family Welfare, Govt. of India with a broad objective to safe guard the health of people of India. Adverse drug Reactions (ADRs) are reported from all over the country to NCC-PvPI, which also work in collaboration with the global ADR monitoring centre (WHO-UMC), Sweden to contribute in the global ADRs data base. NCC-PvPI monitors the ADRs
among Indian population and helps the regulatory authority of India (CDSCO) in taking
decision for safe use of medicines.
So a CME programme on “Pharmacovigilance and ADR Monitoring” will be jointly organized by the Department of Pharmacology and Medical Education Unit, Santiniketan Medical College, Bolpur on 12.08.2021 (Thursday)
to sensitize all the prospective stakeholders of ADR reporting and monitoring. Topics will be discussed on that faculty seminar are as follows:
1. Adverse Drug Reactions- An Overview
2. Pharmacovigilance & ADR Reporting- Why, When & How
3. Severe Cutaneous Adverse Drug Reactions (SCARs) - An Overview
Place: College Lecture Hall-I
Time: 11AM -1 PM
Date: 12.08.2021 (Thursday)
Speakers/Trainers/Resource Persons: Prof. Dr Sukanta Sen, Prof & Head, Dept of Pharmacology, IIMSAR, Haldia [Guest Faculty] and Dr Subham Das, Associate Professor, Dept of Pharmacology, Santiniketan Medical College, Bolpur.
All the cordially invited to attend this seminar at their convenience to make it a grand success.